Infants with biliary atresia exhibit an altered amino acid profile in their newborn screening.
Dried blood spot analysis
Hypermethionemia
Pediatric hepatology
Targeted metabolomics
Journal
Metabolomics : Official journal of the Metabolomic Society
ISSN: 1573-3890
Titre abrégé: Metabolomics
Pays: United States
ID NLM: 101274889
Informations de publication
Date de publication:
05 Oct 2024
05 Oct 2024
Historique:
received:
02
12
2023
accepted:
19
09
2024
medline:
6
10
2024
pubmed:
6
10
2024
entrez:
5
10
2024
Statut:
epublish
Résumé
Biliary atresia (BA) is a rare progressive neonatal cholangiopathy with unknown pathophysiology and time of onset. Newborn Screening (NBS) in Germany is routinely performed in the first days of life to identify rare congenital diseases utilizing dried blood spot (DBS) card analyses. Infants with biliary atresia (BA) are known to have altered amino acid profiles (AAP) at the time point of diagnosis, but it is unclear whether these alterations are present at the time point of NBS. We aimed to analyze amino acid profiles in NBS-DBS of infants with Biliary Atresia. Original NBS-DBS cards of 41 infants who were later on diagnosed with BA were retrospectively obtained. NBS-DBS cards from healthy newborns (n = 40) served as controls. In some BA infants (n = 14) a second DBS card was obtained at time of Kasai surgery. AAP in DBS cards were analyzed by targeted metabolomics. DBS metabolomics in the NBS of at that time point seemingly healthy infants later diagnosed with BA revealed significantly higher levels of Methionine (14.6 ± 8.6 μmol/l), Histidine (23.5 ± 50.3 μmol/l), Threonine (123.9 ± 72.8 μmol/l) and Arginine (14.1 ± 11.8 μmol/l) compared to healthy controls (Met: 8.1 ± 2.6 μmol/l, His: 18.6 ± 10.1 μmol/l, Thr: 98.1 ± 34.3 μmol/l, Arg: 9.3 ± 6.6 μmol/l). Methionine, Arginine and Histidine showed a further increase at time point of Kasai procedure. No correlation between amino acid levels and clinical course was observed. Our data demonstrate that BA patients exhibit an altered AAP within 72 h after birth, long before the infants become symptomatic. This supports the theory of a prenatal onset of the disease and, thus, the possibility of developing a sensitive and specific NBS. Methionine might be particularly relevant due to its involvement in glutathione metabolism. Further investigation of AAP in BA may help in understanding the underlying pathophysiology.
Identifiants
pubmed: 39369162
doi: 10.1007/s11306-024-02175-2
pii: 10.1007/s11306-024-02175-2
doi:
Substances chimiques
Amino Acids
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
109Informations de copyright
© 2024. The Author(s).
Références
Abukawa, D., Ohura, T., Iinuma, K., & Tazawa, Y. (2001). An undescribed subset of neonatal intrahepatic cholestasis associated with multiple hyperaminoacidemia. Hepatology Research: The Official Journal of the Japan Society of Hepatology, 21(1), 8–13. https://doi.org/10.1016/s1386-6346(01)00079-1
doi: 10.1016/s1386-6346(01)00079-1
pubmed: 11470624
Asai, A., Miethke, A., & Bezerra, J. A. (2015). Pathogenesis of biliary atresia: Defining biology to understand clinical phenotypes. Nature Reviews. Gastroenterology & Hepatology, 12(6), 342–352. https://doi.org/10.1038/nrgastro.2015.74
doi: 10.1038/nrgastro.2015.74
Byrd, D. J., Wiltfang, A., Rodeck, B., Latta, A., Burdelski, M., & Brodehl, J. (1993). The plasma amino acid profile and its relationships to standard quantities of liver function in infants and children with extrahepatic biliary atresia and preterminal liver cirrhosis. European Journal of Clinical Chemistry and Clinical Biochemistry: Journal of the Forum of European Clinical Chemistry Societies, 31(4), 197–204. https://doi.org/10.1515/cclm.1993.31.4.197
doi: 10.1515/cclm.1993.31.4.197
pubmed: 8318565
Chen, C.-J., Tang, K.-S., Huang, Y.-H., Chen, C.-L., Huang, L.-T., Chuang, J.-H., & Tiao, M.-M. (2015). The characteristics of antioxidant activity after liver transplantation in biliary atresia patients. BioMed Research International, 2015, 421413. https://doi.org/10.1155/2015/421413
doi: 10.1155/2015/421413
pubmed: 26064908
pmcid: 4443700
Creeden, J. F., Kipp, Z. A., Xu, M., Flight, R. M., Moseley, H. N. B., Martinez, G. J., Lee, W.-H., Alganem, K., Imami, A. S., McMullen, M. R., Roychowdhury, S., Nawabi, A. M., Hipp, J. A., Softic, S., Weinman, S. A., McCullumsmith, R., Nagy, L. E., & Hinds, T. D. (2022). Hepatic kinome atlas: An in-depth identification of kinase pathways in liver fibrosis of humans and rodents. Hepatology (Baltimore, Md.), 76(5), 1376–1388. https://doi.org/10.1002/hep.32467
Dever, J. T., & Elfarra, A. A. (2010). The biochemical and toxicological significance of hypermethionemia: New insights and clinical relevance. Expert Opinion on Drug Metabolism & Toxicology, 6(11), 1333–1346. https://doi.org/10.1517/17425255.2010.522177
doi: 10.1517/17425255.2010.522177
du Preez, I., Luies, L., & Loots, D. T. (2017). Metabolomics biomarkers for tuberculosis diagnostics: Current status and future objectives. Biomarkers in Medicine, 11(2), 179–194. https://doi.org/10.2217/bmm-2016-0287
doi: 10.2217/bmm-2016-0287
pubmed: 28097879
El-Batch, M., Ibrahim, W., & Said, S. (2011). Effect of histidine on autotaxin activity in experimentally induced liver fibrosis. Journal of Biochemical and Molecular Toxicology, 25(3), 143–150. https://doi.org/10.1002/jbt.20370
doi: 10.1002/jbt.20370
pubmed: 20957682
Harpavat, S., Finegold, M. J., & Karpen, S. J. (2011). Patients with biliary atresia have elevated direct/conjugated bilirubin levels shortly after birth. Pediatrics, 128(6), e1428–e1433. https://doi.org/10.1542/peds.2011-1869
doi: 10.1542/peds.2011-1869
pubmed: 22106076
pmcid: 3387898
Holecek, M. (2015). Ammonia and amino acid profiles in liver cirrhosis: Effects of variables leading to hepatic encephalopathy. Nutrition (Burbank, Los Angeles County, Calif.), 31(1), 14–20. https://doi.org/10.1016/j.nut.2014.03.016
Hollywood, K., Brison, D. R., & Goodacre, R. (2006). Metabolomics: Current technologies and future trends. Proteomics, 6(17), 4716–4723. https://doi.org/10.1002/pmic.200600106
doi: 10.1002/pmic.200600106
pubmed: 16888765
Jimenez-Rivera, C., Jolin-Dahel, K. S., Fortinsky, K. J., Gozdyra, P., & Benchimol, E. I. (2013). International incidence and outcomes of biliary atresia. Journal of Pediatric Gastroenterology and Nutrition, 56(4), 344–354. https://doi.org/10.1097/MPG.0b013e318282a913
doi: 10.1097/MPG.0b013e318282a913
pubmed: 23263590
Kelley-Quon, L. I., Shue, E., Burke, R. V., Smith, C., Kling, K., Mahdi, E., Ourshalimian, S., Fenlon, M., Dellinger, M., Shew, S. B., Lee, J., Padilla, B., Inge, T., Roach, J., Marwan, A. I., Russell, K. W., Ignacio, R., Fialkowski, E., Nijagal, A., & Wang, K. (2022). The need for early Kasai portoenterostomy: A Western Pediatric Surgery Research Consortium study. Pediatric Surgery International, 38(2), 193–199. https://doi.org/10.1007/s00383-021-05047-1
doi: 10.1007/s00383-021-05047-1
pubmed: 34854975
Kumar, A., & Misra, B. B. (2019). Challenges and opportunities in cancer metabolomics. Proteomics, 19(21–22), e1900042. https://doi.org/10.1002/pmic.201900042
doi: 10.1002/pmic.201900042
pubmed: 30950571
Lampela, H., Ritvanen, A., Kosola, S., Koivusalo, A., Rintala, R., Jalanko, H., & Pakarinen, M. (2012). National centralization of biliary atresia care to an assigned multidisciplinary team provides high-quality outcomes. Scandinavian Journal of Gastroenterology, 47(1), 99–107. https://doi.org/10.3109/00365521.2011.627446
doi: 10.3109/00365521.2011.627446
pubmed: 22171974
Madadi-Sanjani, O., Blaser, J., Voigt, G., Kuebler, J. F., & Petersen, C. (2019). Home-based color card screening for biliary atresia: The first steps for implementation of a nationwide newborn screening in Germany. Pediatric Surgery International, 35(11), 1217–1222. https://doi.org/10.1007/s00383-019-04526-w
doi: 10.1007/s00383-019-04526-w
pubmed: 31346695
Mong, M., Chao, C., & Yin, M. (2011). Histidine and carnosine alleviated hepatic steatosis in mice consumed high saturated fat diet. European Journal of Pharmacology, 653(1–3), 82–88. https://doi.org/10.1016/j.ejphar.2010.12.001
doi: 10.1016/j.ejphar.2010.12.001
pubmed: 21167151
Morel, B., Kolanska, K., Dhombres, F., Jouannic, J. M., Franchi-Abella, S., Ducou Le Pointe, H., & Garel, C. (2015). Prenatal ultrasound diagnosis of cystic biliary atresia. Clinical Case Reports, 3(12), 1050–1051. https://doi.org/10.1002/ccr3.442
doi: 10.1002/ccr3.442
pubmed: 26734144
pmcid: 4693700
Muller, F., Gauthier, F., Laurent, J., Schmitt, M., & Boué, J. (1991). Amniotic fluid GGT and congenital extrahepatic biliary damage. Lancet (London, England), 337(8735), 232–233. https://doi.org/10.1016/0140-6736(91)92192-5
doi: 10.1016/0140-6736(91)92192-5
pubmed: 1670856
Paulusma, C. C., Lamers, W. H., Broer, S., & van de Graaf, S. F. J. (2022). Amino acid metabolism, transport and signalling in the liver revisited. Biochemical Pharmacology, 201, 115074. https://doi.org/10.1016/j.bcp.2022.115074
doi: 10.1016/j.bcp.2022.115074
pubmed: 35568239
Petersen, C., & Davenport, M. (2013). Aetiology of biliary atresia: What is actually known? Orphanet Journal of Rare Diseases, 8, 128. https://doi.org/10.1186/1750-1172-8-128
doi: 10.1186/1750-1172-8-128
pubmed: 23987231
pmcid: 3766137
Rishi, P., Bharrhan, S., Singh, G., & Kaur, I. P. (2011). Effect of Lactobacillus plantarum and L-arginine against endotoxin-induced liver injury in a rat model. Life Sciences, 89(23–24), 847–853. https://doi.org/10.1016/j.lfs.2011.09.007
doi: 10.1016/j.lfs.2011.09.007
pubmed: 21958471
Serinet, M.-O., Wildhaber, B. E., Broué, P., Lachaux, A., Sarles, J., Jacquemin, E., Gauthier, F., & Chardot, C. (2009). Impact of age at Kasai operation on its results in late childhood and adolescence: A rational basis for biliary atresia screening. Pediatrics, 123(5), 1280–1286. https://doi.org/10.1542/peds.2008-1949
doi: 10.1542/peds.2008-1949
pubmed: 19403492
Spiekerkötter, U., & Krude, H. (2022). Target diseases for neonatal screening in Germany—challenges for treatment and long-term care. Deutsches Ärzteblatt International. https://doi.org/10.3238/arztebl.m2022.0075
doi: 10.3238/arztebl.m2022.0075
Szeremeta, M., Pietrowska, K., Niemcunowicz-Janica, A., Kretowski, A., & Ciborowski, M. (2021). Applications of metabolomics in forensic toxicology and forensic medicine. International Journal of Molecular Sciences, 22(6), 3010. https://doi.org/10.3390/ijms22063010
doi: 10.3390/ijms22063010
pubmed: 33809459
pmcid: 8002074
Tiao, M.-M., Lin, T.-K., Kuo, F.-Y., Huang, C.-C., Du, Y.-Y., Chen, C.-L., & Chuang, J.-H. (2007). Early stage of biliary atresia is associated with significant changes in 8-hydroxydeoxyguanosine and mitochondrial copy number. Journal of Pediatric Gastroenterology and Nutrition, 45(3), 329–334. https://doi.org/10.1097/MPG.0b013e3180cc2c0f
doi: 10.1097/MPG.0b013e3180cc2c0f
pubmed: 17873745
Tietge, U. J. F., Bahr, M. J., Manns, M. P., & Böker, K. H. W. (2003). Hepatic amino-acid metabolism in liver cirrhosis and in the long-term course after liver transplantation. Transplant International: Official Journal of the European Society for Organ Transplantation, 16(1), 1–8. https://doi.org/10.1007/s00147-002-0484-z
doi: 10.1007/s00147-002-0484-z
pubmed: 12545334
Valero, R., García-Valdecasas, J. C., Net, M., Beltran, J., Ordi, J., González, F. X., López-Boado, M. A., Almenara, R., Taurá, P., Elena, M., Capdevila, L., Manyalich, M., & Visa, J. (2000). L-arginine reduces liver and biliary tract damage after liver transplantation from non-heart-beating donor pigs. Transplantation, 70(5), 730–737. https://doi.org/10.1097/00007890-200009150-00004
doi: 10.1097/00007890-200009150-00004
pubmed: 11003349
Waisbourd-Zinman, O., Koh, H., Tsai, S., Lavrut, P.-M., Dang, C., Zhao, X., Pack, M., Cave, J., Hawes, M., Koo, K. A., Porter, J. R., & Wells, R. G. (2016). The toxin biliatresone causes mouse extrahepatic cholangiocyte damage and fibrosis through decreased glutathione and SOX17. Hepatology (Baltimore, Md.), 64(3), 880–893. https://doi.org/10.1002/hep.28599
Wang, J., Xu, J., Xia, M., Yang, Y., Shen, Z., Chen, G., Dong, R., & Zheng, S. (2019). Correlation between hepatic oxidative damage and clinical severity and mitochondrial gene sequencing results in biliary atresia. Hepatology Research: The Official Journal of the Japan Society of Hepatology, 49(6), 695–704. https://doi.org/10.1111/hepr.13324
doi: 10.1111/hepr.13324
pubmed: 30811072
Weisdorf, S. A., Freese, D. K., Fath, J. J., Tsai, M. Y., & Cerra, F. B. (1987). Amino acid abnormalities in infants with extrahepatic biliary atresia and cirrhosis. Journal of Pediatric Gastroenterology and Nutrition, 6(6), 860–864. https://doi.org/10.1097/00005176-198711000-00007
doi: 10.1097/00005176-198711000-00007
pubmed: 3681571
Yan, S.-L., Wu, S.-T., Yin, M.-C., Chen, H.-T., & Chen, H.-C. (2009). Protective effects from carnosine and histidine on acetaminophen-induced liver injury. Journal of Food Science, 74(8), H259-265. https://doi.org/10.1111/j.1750-3841.2009.01330.x
doi: 10.1111/j.1750-3841.2009.01330.x
pubmed: 19799668
Yang, L., Zhou, Y., Xu, P.-P., Mourya, R., Lei, H.-Y., Cao, G.-Q., Xiong, X.-L., Xu, H., Duan, X.-F., Wang, N., Fei, L., Chang, X.-P., Zhang, X., Jiang, M., Bezerra, J. A., & Tang, S.-T. (2018). Diagnostic accuracy of serum matrix metalloproteinase-7 for biliary atresia. Hepatology (Baltimore, Md.), 68(6), 2069–2077. https://doi.org/10.1002/hep.30234
Zhao, D., Han, L., He, Z., Zhang, J., & Zhang, Y. (2014). Identification of the plasma metabolomics as early diagnostic markers between biliary atresia and neonatal hepatitis syndrome. PLoS ONE, 9(1), e85694. https://doi.org/10.1371/journal.pone.0085694
doi: 10.1371/journal.pone.0085694
pubmed: 24416443
pmcid: 3885726
Zhao, X., Lorent, K., Wilkins, B. J., Marchione, D. M., Gillespie, K., Waisbourd-Zinman, O., So, J., Koo, K. A., Shin, D., Porter, J. R., Wells, R. G., Blair, I., & Pack, M. (2016). Glutathione antioxidant pathway activity and reserve determine toxicity and specificity of the biliary toxin biliatresone in zebrafish. Hepatology (Baltimore, Md.), 64(3), 894–907. https://doi.org/10.1002/hep.28603
Zukunft, S., Sorgenfrei, M., Prehn, C., Möller, G., & Adamski, J. (2013). Targeted metabolomics of dried blood spot extracts. Chromatographia, 76(19–20), 1295–1305. https://doi.org/10.1007/s10337-013-2429-3
doi: 10.1007/s10337-013-2429-3